NCT00706277

Brief Summary

The aim of the study is to investigate the effects of total intravenous anesthesia (TIVA; propofol, remifentanil) and balanced anesthesia (BAL; induction with propofol and fentanyl; maintenance of anesthesia with sevoflurane and nitrous oxide) on pulmonary function 30 minutes after emergence from the general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jun 2008

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

June 25, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 27, 2008

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

February 10, 2009

Status Verified

February 1, 2009

First QC Date

June 25, 2008

Last Update Submit

February 9, 2009

Conditions

Keywords

forced vital capacityforced expired volume in 1 s

Outcome Measures

Primary Outcomes (1)

  • FEV1 forced expiratory volume; FVC forced vital capacity

    preoperative, 30 minutes postoperative

Study Arms (2)

TIVA

ACTIVE COMPARATOR

patients receiving total intravenous anesthesia (TIVA)

Drug: propofolDrug: remifentanil

balanced

ACTIVE COMPARATOR

patients receiving balanced anesthesia

Drug: propofolDrug: fentanylDrug: Sevoflurane/Nitrous Oxide

Interventions

propofol 2mg/kg for induction of anesthesia; followed by propofol 6 mg/kg/hour

TIVA

remifentanil 0,25mcg/kg/hour

TIVA

fentanyl 100mcg

balanced

maintenance of anesthesia with sevoflurane and nitrous oxide

balanced

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA 1-2
  • BMI normal

You may not qualify if:

  • lung disease
  • Nicotine abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

TILAK Hospitals

Innsbruck, 6020, Austria

Location

Related Publications (3)

  • Gunnarsson L, Lindberg P, Tokics L, Thorstensson O, Thorne A. Lung function after open versus laparoscopic cholecystectomy. Acta Anaesthesiol Scand. 1995 Apr;39(3):302-6. doi: 10.1111/j.1399-6576.1995.tb04066.x.

    PMID: 7793205BACKGROUND
  • Regli A, von Ungern-Sternberg BS, Reber A, Schneider MC. Impact of spinal anaesthesia on peri-operative lung volumes in obese and morbidly obese female patients. Anaesthesia. 2006 Mar;61(3):215-21. doi: 10.1111/j.1365-2044.2005.04441.x.

    PMID: 16480344BACKGROUND
  • Natalini G, Franceschetti ME, Pletti C, Recupero D, Lanza G, Bernardini A. Impact of laryngeal mask airway and tracheal tube on pulmonary function during the early postoperative period. Acta Anaesthesiol Scand. 2002 May;46(5):525-8. doi: 10.1034/j.1399-6576.2002.460509.x.

    PMID: 12027846BACKGROUND

MeSH Terms

Interventions

PropofolRemifentanilFentanylSevofluraneNitrous Oxide

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsMethyl EthersEthersHydrocarbons, FluorinatedHydrocarbons, HalogenatedNitrogen OxidesGasesInorganic ChemicalsNitrogen CompoundsOxidesOxygen Compounds

Study Officials

  • Arnulf Benzer, MD

    TILAK Hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 25, 2008

First Posted

June 27, 2008

Study Start

June 1, 2008

Study Completion

December 1, 2008

Last Updated

February 10, 2009

Record last verified: 2009-02

Locations